Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Oral Oncol. 2012 Feb 15;48(6):523–529. doi: 10.1016/j.oraloncology.2012.01.010

Figure 5. Hypoglycosylated E-cadherin variant, V13, interferes with CAL27 cell growth and migration and enhances intercellular adhesion.

Figure 5

(A) Western blot of V13 and E-cad. (B) Growth curves of untransfected, E-cad- and V13-transfected cells (*p<0.05). (C) Transepithelial resistance (TER) in untransfected, E-cad- and V13-transfected cells (**p< 0.01).(D) Transwell migration assays of untransfected, E-cad- and V13-transfected cells (**p< 0.01 and ***p< 0.001). (E) Scratch- wound assays of untransfected, E-cad- and V13-transfected cells. Size bar: 50 μm.